340B PATIENTS Act of 2025
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- Senate
- Sponsors
- 3
- Latest action
- Jul 22, 2025
What it does
The 340B PATIENTS Act of 2025 would clarify and strengthen the 340B drug discount program by requiring drug manufacturers to provide discounted prices to covered entities regardless of where or how the drugs are dispensed, including through contract pharmacies, and prohibiting manufacturers from imposing conditions that limit access to those discounted drugs. It affects drug manufacturers, covered entities (such as hospitals, clinics, and health centers), and patients who rely on these entities for affordable medications, particularly specialty drugs. The bill establishes civil monetary penalties of up to $2 million per day for manufacturers who intentionally violate these requirements, and…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
Where it goes next
While a bill can still move, the questions are about people and money.